E. BioTron Medical, Inc. Brent Bush, CFO of a medical device distributor, BioTron Medical, Inc., was approached by a Japanese customer, Numata, with a proposal to pay cash (in yen) for its typical orders of 12,500,000 every other month if it were given a 4.5% discount. Numatas current terms are 30 days with no discounts. Using the following quotes and estimated cost of capital for Numata, Bush will compare the pro-posal with covering yen payments with forward con-tracts. Should Brent Bush accept Numatas proposal? Spot rate:111.40/$ 30-day forward rate: 111.00/$ 90-day forward rate: 110.40/$ 180-day forward rate:109.20/$ Numatas WACC 8.850% BioTrons WACC 9.200%